July / August 2022

Features

Does vitrectomy have a place for treatment of DME?

Why we need to reconsider the role of vitrectomy in the management of diabetic macular edema.

RRD repair: Updates and current perspectives

An update on longer-lasting agents, alternative therapies, novel delivery systems and technology that aims to relieve treatment burden.

More durable therapies for nAMD: Where we stand

An update on longer-lasting agents, alternative therapies, novel delivery systems and technology that aims to relieve treatment burden.

Lessons from COVID-19 for the next pandemic

Five retina specialists share what they've learned from the past two years that would serve practices and policy makers well in the next wave or outbreak.

Gene therapy, heads-up surgery, AI and PTI

Four standout abstracts provide new insights into novel treatments and technologies in retina.

Departments

Coding Commentary

Surprise! It's the No Surprises Act

How to navigate the regulations when providing care to out-of-network and private-pay patients.

Editor's Page

News

North of the Border

AMD consensus nomenclature explained

An overview of the variants of age-related macular degeneration and their mimickers.

Retina Rounds

Anticoagulation and a second RVO

Managing retinal vein occlusion in a patient with a history of thrombophilia.

Surgical Pearl Video

Pearls for righting aqueous misdirection

How to do a pars plana vitrectomy with irido-zonulo-hyaloidectomy when laser and medical therapy fail.